SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: snerd who wrote (14369)5/10/1999 7:03:00 PM
From: xcr600  Read Replies (1) | Respond to of 56535
 
ZONA- Technically oversold, but the "drug" being developed is a joke and ineffective. You don't want to be holding this one for long if you're playing a bounce. There is a reason the stock has a very high short interest, and shorts eventually are proven right.

x




To: snerd who wrote (14369)5/10/1999 11:57:00 PM
From: StockHawk  Respond to of 56535
 
Snerd,

I agree with xcr, ZONA is likely to fall further. Their drug is hardly better than a placebo - the stock has held up beyond reason on hope of Viagra-like hype. They are probably still a good short, even after today's fall. (It may have alreay had its bounce after the morning's low.) Zona is a one trick pony and the pony is lame. Would hate to see you get burned on this one.

Just mho, of course. (I am short ZONA)

StockHawk


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News